Join us for a virtual Key Opinion Leader (KOL) webinar with Actinium Pharmaceuticals featuring KOL Sergio A. Giralt, MD (Memorial Sloan Kettering Cancer Center) who will discuss the results from the recently completed pivotal Phase 3 SIERRA trial of Iomab-B, which were presented in a late-breaker presentation at the Transplantation & Cellular Therapy (TCT) tandem meetings on February 18, 2023.  

A live question and answer session will follow the formal presentations.